{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:10:47Z","timestamp":1785935447528,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cpcardiol.2023.101927","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T02:17:03Z","timestamp":1689214623000},"page":"101927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5612-8626","authenticated-orcid":false,"given":"Ahmed Kamal","family":"Siddiqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushood","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwar","family":"Dhawadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiba","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Osama","family":"Muslim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fizza","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cpcardiol.2023.101927_bib0001","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.567","article-title":"Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System","volume":"18","author":"Christ","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101927_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101927_bib0003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2019.09.039","article-title":"Meta-analysis comparing torsemide versus furosemide in patients with heart failure","volume":"125","author":"Abraham","year":"2020","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.cpcardiol.2023.101927_bib0004","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.cpcardiol.2023.101927_bib0005","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ahj.2014.12.009","article-title":"A reappraisal of loop diuretic choice in heart failure patients","volume":"169","author":"Buggey","year":"2015","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101927_bib0007","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"Cos\u00edn","year":"2002","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101927_bib0008","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0009","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amjcard.2015.10.059","article-title":"Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF Trial)","volume":"117","author":"Mentz","year":"2016","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101927_bib0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","article-title":"Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV\u2013efficacy and quality of life","volume":"5","author":"M\u00fcller","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0011","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.japh.2019.01.014","article-title":"Comparing torsemide versus furosemide in patients with heart failure: a meta-analysis","volume":"59","author":"Kido","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0012","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jep.13261","article-title":"Torasemide versus furosemide in treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Sherif","year":"2020","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0013","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial","volume":"329","author":"Mentz","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2023.101927_bib0014","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2023.101927_bib0015","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2023.101927_bib0016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"10","key":"10.1016\/j.cpcardiol.2023.101927_bib0018","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/hrt.2005.079764","article-title":"Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00044011-200525030-00002","article-title":"High-dose torasemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure","volume":"25","author":"Paterna","year":"2005","journal-title":"Clin Drug Investig"},{"issue":"9","key":"10.1016\/j.cpcardiol.2023.101927_bib0020","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.clinthera.2011.08.006","article-title":"Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study","volume":"33","year":"2011","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101927_bib0021","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1253\/circj.67.384","article-title":"Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure","volume":"67","author":"Yamato","year":"2003","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101927_bib0022","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0149-2918(99)80007-1","article-title":"A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure","volume":"21","author":"Noe","year":"1999","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0023","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.4238\/2014.September.5.11","article-title":"Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure","volume":"13","author":"Han","year":"2014","journal-title":"Genet Mol Res"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101927_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10557-018-6843-5","article-title":"Comparative analysis of long-term outcomes of torasemide and furosemide in heart failure patients in heart failure registries of the european society of cardiology","volume":"33","author":"Oziera\u0144ski","year":"2019","journal-title":"Cardiovasc Drugs Ther."},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101927_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12872-019-1112-5","article-title":"Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study","volume":"19","author":"Rahhal","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101927_bib0026","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FJC.0000000000000212","article-title":"Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital","volume":"65","author":"Mentz","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101927_bib0027","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ejhf.960","article-title":"Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)","volume":"20","author":"Trippel","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101927_bib0028","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1742-1241.1998.tb08911.x","article-title":"Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint","volume":"52","author":"Spannheimer","year":"1998","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101927_bib0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00019053-200017050-00002","article-title":"Healthcare costs of patients with heart failure treated with torasemide or furosemide","volume":"17","author":"Stroupe","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101927_bib0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2459\/JCM.0000000000000794","article-title":"Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis","volume":"20","author":"Miles","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101927_bib0031","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2217\/fca.12.54","article-title":"Should torsemide be the loop diuretic of choice in systolic heart failure?","volume":"8","author":"DiNicolantonio","year":"2012","journal-title":"Future Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101927_bib0032","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.ejim.2018.08.015","article-title":"Torsemide versus furosemide in heart failure patients: a meta-analysis of randomized controlled trials","volume":"57","author":"Shah","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101927_bib0033","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/fca.15.56","article-title":"Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial","volume":"11","author":"Mentz","year":"2015","journal-title":"Future Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101927_bib0034","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101927_bib0035","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","article-title":"Furosemide and the progression of left ventricular dysfunction in experimental heart failure","volume":"44","author":"McCurley","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2023.101927_bib0036","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"L\u00f3pez","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.cpcardiol.2023.101927_bib0037","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"L\u00f3pez","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.cpcardiol.2023.101927_bib0038","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","article-title":"Myocardial interstitial fibrosis in heart failure: biological and translational perspectives","volume":"71","author":"Gonz\u00e1lez","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:24:34Z","timestamp":1758939874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0146280623003444"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101927","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101927"}}